Researchers have discovered that the blood-brain barrier is temporarily disrupted following glioblastoma surgery, potentially allowing chemotherapy to be more effective if administered sooner. This finding could challenge the standard four-to-six-week wait for treatment, offering a new approach to targeting cancer cells left behind after an operation.